Pulse biosciences, inc. (PLSE)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15
ASSETS
Current assets:
Cash and cash equivalents

7,864

6,899

9,570

10,780

8,536

51,103

6,331

6,794

10,667

3,386

32,423

1,990

2,751

2,089

4,628

20,214

2,105

3,606

Investments

8,022

18,499

-

-

-

8,480

-

-

-

34,683

-

-

-

14,306

-

-

-

-

Investments

-

-

24,928

31,862

44,265

-

14,690

20,705

22,708

-

9,618

13,409

16,109

-

-

-

-

-

Investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,085

495

-

-

Prepaid expenses and other current assets

545

1,005

1,437

1,908

550

779

1,095

1,161

368

412

512

717

253

268

294

337

47

44

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

493

347

Total current assets

16,431

26,403

35,935

44,550

53,351

60,362

22,116

28,660

33,743

38,481

42,553

16,116

19,113

16,663

19,007

21,046

2,645

3,997

Property and equipment, net

2,633

2,566

2,428

1,985

2,056

2,173

2,339

2,432

2,451

2,570

2,635

2,730

293

317

323

344

346

329

Intangible assets, net

4,381

4,547

4,713

4,880

5,046

5,213

5,379

5,545

5,712

5,878

6,044

6,210

6,377

6,543

6,709

6,876

7,042

7,208

Goodwill

2,791

2,791

2,791

2,791

2,791

2,791

2,791

2,791

2,791

2,791

2,791

2,791

2,791

2,791

2,791

2,791

2,791

2,791

Right-of-use assets

5,043

5,114

1,190

1,182

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other asset

562

494

1,645

1,645

208

101

101

101

101

101

101

101

-

-

-

-

-

-

Total assets

31,841

41,915

48,702

57,033

63,452

70,640

32,726

39,529

44,798

49,821

54,124

27,948

28,574

26,314

28,830

31,057

12,824

14,325

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

1,214

1,963

1,816

1,577

1,200

1,272

1,281

1,502

944

782

914

851

782

265

446

333

296

262

Accrued expenses

2,071

2,496

2,054

1,703

1,519

1,421

1,657

1,164

846

1,034

1,168

818

460

751

521

257

354

398

Deferred rent, current

-

-

-

-

-

415

410

406

401

397

392

303

-

-

-

-

-

-

Lease liability, current

98

-

177

168

396

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

3,383

4,459

4,047

3,448

3,115

3,108

3,348

3,072

2,191

2,213

2,474

1,972

1,242

1,016

967

590

650

660

Deferred rent, net of current

-

-

-

-

-

1,198

1,304

1,410

1,512

1,613

1,715

1,816

-

-

-

-

-

-

Lease liability, less current

6,690

6,719

3,674

3,724

1,223

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

10,073

11,178

7,721

7,172

4,338

4,306

4,652

4,482

3,703

3,826

4,189

3,788

-

1,016

-

-

-

-

Commitments and contingencies (Note 8)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

Stockholders' equity:
Preferred stock, $0.001 par value; authorized – 50,000 shares; no shares issued and outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

Common stock, $0.001 par value: authorized – 500,000 shares; issued and outstanding – 20,869 shares and 20,825 shares at March 31, 2020 and December 31, 2019, respectively

21

21

21

21

21

21

17

17

17

17

16

15

14

13

13

13

8

8

Additional paid-in-capital

156,291

153,401

149,853

146,973

144,887

142,032

94,825

91,034

87,922

84,202

79,391

46,135

43,131

37,898

37,655

37,484

16,938

16,745

Accumulated other comprehensive income

17

4

8

22

2

-1

-3

-

-3

-51

-2

-6

-9

-7

-8

-

-

-

Accumulated deficit

-134,561

-122,689

-108,901

-97,155

-85,796

-75,718

-66,765

-56,004

-46,841

-38,173

-29,470

-21,984

-15,804

-12,606

-9,797

-7,030

-4,772

-3,088

Total stockholders' equity

21,768

30,737

40,981

49,861

59,114

66,334

28,074

35,047

41,095

45,995

49,935

24,160

27,332

25,298

27,863

30,467

12,174

13,665

Total liabilities and stockholders' equity

31,841

41,915

48,702

57,033

63,452

70,640

32,726

39,529

44,798

49,821

54,124

27,948

28,574

26,314

28,830

31,057

12,824

14,325